Abstract
Arboviruses of the families Togaviridae and Flaviviridae are widely distributed and are important causative agents of viral encephalitis, a severe and often fatal disease. The only internationally available vaccine against these diseases is expensive and laborious to manufacture and difficult to administer. Therefore, new vaccines are required against these pathogens. This study investigates the use of a DNA-prime, orally delivered protein boost vaccination strategy against viral encephalitis. This vaccination strategy was immunogenic and provided partial protection against viral encephalitis in a murine model, demonstrating the possible applicability of this vaccination strategy for the management of endemic encephalitis.
Article PDF
Avoid common mistakes on your manuscript.
References
Berg SW, Mitchell BS, Hanson RK, Olafson RP, Williams RP, Tueller JE, Burton RJ, Novak DM, Tsai TF, Wignall FS (1997). Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine. Clin Infect Dis 24: 265–266.
Binder GK, Griffin DE (2001). Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 293: 303–306.
Chen HW, Pan CH, Liau MY, Jou R, Tsai CJ, Wu HJ, Lin YL, Tao MH (1999). Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 73: 10137–10145.
Deliyannis G, Boyle JS, Brady JL, Brown LE, Lew AM (2000). A fusion DNA vaccine that targets antigenpresenting cells increases protection from viral challenge. Proc Nat lAcad Sci USA 97: 6676–6680.
Dropulic LK, Hardwick JM, Griffin DE (1997). A single amino acid change in the E2 glycoprotein of Sindbis virus confers neurovirulence by altering an early step of virus replication. J Virol 71: 6100–6105.
Griffin DE (1981). Immunoglobulins in the cerebrospinal fluid: changes during acute viral encephalitis in mice. J Immunol 126: 27–31.
Griffin DE, Johnson RT (1977). Role of the immune response in recovery from Sindbis virus encephalitis in mice. J Immunol 118: 1070–1075.
Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den Hurk AF, Pyke AT, Johansen CA, Mackenzie JS (1999). Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust 170: 533–536.
Hanna JN, Ritchie SA, Phillips DA, Shield J, Bailey MC, Mackenzie JS, Poidinger M, McCall BJ, Mills PJ (1996). An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 165: 256–260.
Igarashi A, Tanaka M, Morita K, Takasu T, Ahmed A, Akram DS, Waqar MA (1994). Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan. Microbiol Immunol 38: 827–830.
Jan JT, Griffin DE (1999). Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication. J Virol 73: 10296–10302.
Labrada L, Liang XH, Zheng W, Johnston C, Levine B (2002). Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J Virol 76: 11688–11703.
Levine B, Hardwick JM, Trapp BD, Crawford TO, Bollinger RC, Griffin DE (1991). Antibody-mediated clearance of alphavirus infection from neurons. Science 254: 856–860.
Maharaj I, Froh KJ, Campbell JB (1986). Immune responses of mice to inactivated rabies vaccine administered orally: potentiation by Quillaja saponin. Can J Microbiol 32: 414–420.
Nargi-Aizenman JL, Griffin DE (2001). Sindbis virusinduced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-d-aspartate receptor antagonists. J Virol 75: 7114–7121.
Perkins SD, O’Brien LM, Phillpotts RJ (2006). Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination. Vaccine 24: 3440–3445.
Pickering RJ, Smith SD, Strugnell RA, Wesselingh SL, Webster DE (2006). Crude saponins improve the immune response to an oral plant-made measles vaccine. Vaccine 24: 144–150.
Ramakrishna C, Desai A, Shankar SK, Chandramuki A, Ravi V (1999). Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response. Vaccine 17: 3102–3108.
Rowell JF, Griffin DE (2002). Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis. J Neuroimmunol 127: 106–114.
Schoepp RJ, Johnston RE (1993). Directed mutagenesis of a Sindbis virus pathogenesis site. Virology 193: 149–159.
Tsai TF, Chang GJ, Yu YX (1999). Japanese Encephalitis Vaccines. In: Vaccines. Plotkin SA, Orenstein WA (eds). Philadelphia: WB Saunders, pp 672–710.
Ubol S, Levine B, Lee SH, Greenspan NS, Griffin DE (1995). Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-mediated downregulation of Sindbis virus replication in persistently infected neurons. J Virol 69: 1990–1993.
WHO (2006). Japanese encephalitis vaccines. Wkly Epidemiol Rec 81: 331–340.
Zheng BJ, Ng MH, Chan KW, Tam S, Woo PC, Ng SP, Yuen KY (2002). A single dose of oral DNA immunization delivered by attenuated Salmonella typhimurium down-regulates transgene expression in HBsAg transgenic mice. Eur J Immunol 32: 3294–3304.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by grants from the Australian National Health and Medical Research Council (NHMRC) to S.L.W. (358399).
Rights and permissions
About this article
Cite this article
Zanin, M.P., Webster, D.E. & Wesselingh, S.L. A DNA prime, orally delivered protein boost vaccination strategy against viral encephalitis. Journal of NeuroVirology 13, 284–289 (2007). https://doi.org/10.1080/13550280701329646
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280701329646